HEALWELL AI(HWAIF)
$0.41-0.00 (-0.72%)
HWAIF
HEALWELL AI financials statements
$0.41
At close:-0.00 (-0.72%)
HEALWELL AI (HWAIF) Ratios
8 Followers
HEALWELL AI Ratios
HWAIF's free cash flow for Q2 2026 was C$-2.57M. For the 2026 fiscal year, HWAIF's free cash flow was decreased by C$-2.12M and operating cash flow was C$-447.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.91 | 0.79 | 2.42 | 0.44 | 1.14 |
| Quick Ratio | 0.91 | 0.79 | 2.42 | 0.44 | 1.14 |
| Cash Ratio | 0.26 | 0.40 | 2.03 | 0.07 | 0.49 |
| Solvency Ratio | -0.19 | -0.37 | -0.93 | -0.58 | -0.36 |
| Operating Cash Flow Ratio | -0.27 | -0.97 | -1.15 | -0.43 | -0.49 |
| Short-Term Operating Cash Flow Coverage | -0.81 | -12.71 | -16.07 | -1.19 | 0.00 |
| Net Current Asset Value | C$ -96.37M | C$ -33.53M | C$ -9.48M | C$ -23.53M | C$ -14.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.18 | 0.39 | 0.38 | 0.24 |
| Debt-to-Equity Ratio | 0.69 | 0.35 | 1.65 | 1.48 | 0.51 |
| Debt-to-Capital Ratio | 0.41 | 0.26 | 0.62 | 0.60 | 0.34 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.18 | 0.54 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.30 | 1.96 | 4.24 | 3.88 | 2.17 |
| Debt Service Coverage Ratio | -0.37 | -4.00 | -23.17 | -1.98 | -19.99 |
| Interest Coverage Ratio | -2.91 | -12.86 | 0.00 | -28.39 | -30.72 |
| Debt to Market Cap | 0.38 | 0.06 | 0.38 | 0.23 | 0.00 |
| Interest Debt Per Share | 0.38 | 0.18 | 0.37 | 0.36 | 0.31 |
| Net Debt to EBITDA | -5.08 | -0.69 | -0.11 | -1.15 | -0.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.91% | 44.43% | 17.18% | 35.59% | 31.39% |
| EBIT Margin | -29.08% | -65.87% | -240.43% | -157.89% | -33.10% |
| EBITDA Margin | -12.80% | -47.26% | -220.21% | -133.71% | -23.93% |
| Operating Profit Margin | -28.44% | -86.10% | -240.43% | -168.34% | -34.37% |
| Pretax Profit Margin | -38.32% | -72.57% | -446.67% | -163.81% | -34.06% |
| Net Profit Margin | -45.22% | -67.47% | -431.83% | -202.27% | -32.77% |
| Continuous Operations Profit Margin | -37.68% | -70.37% | -439.26% | -174.55% | -32.50% |
| Net Income Per EBT | 117.99% | 92.97% | 96.68% | 123.48% | 96.21% |
| EBT Per EBIT | 134.73% | 84.29% | 185.78% | 97.31% | 99.11% |
| Return on Assets (ROA) | -16.47% | -20.94% | -58.84% | -46.21% | -25.73% |
| Return on Equity (ROE) | -37.87% | -41.16% | -249.78% | -179.07% | -55.91% |
| Return on Capital Employed (ROCE) | -13.78% | -32.83% | -39.73% | -66.87% | -35.42% |
| Return on Invested Capital (ROIC) | -12.07% | -31.01% | -37.64% | -51.12% | -31.69% |
| Return on Tangible Assets | -59.03% | -87.38% | -109.39% | -86.74% | -40.84% |
| Earnings Yield | -22.30% | -9.19% | -75.89% | -70.18% | -26.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.65 | 6.19 | 5.90 | 1.85 | 7.56 |
| Payables Turnover | 4.42 | 5.00 | 1.54 | 1.17 | 4.85 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 20.43 | 7.93 | 1.96 | 1.00 | 3.43 |
| Asset Turnover | 0.36 | 0.31 | 0.14 | 0.23 | 0.79 |
| Working Capital Turnover Ratio | -18.72 | 9.34 | 5.73 | -2.38 | -32.45 |
| Cash Conversion Cycle | 55.45 | -14.09 | -174.86 | -113.66 | -27.00 |
| Days of Sales Outstanding | 137.96 | 58.96 | 61.91 | 197.03 | 48.30 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 82.51 | 73.04 | 236.77 | 310.69 | 75.30 |
| Operating Cycle | 137.96 | 58.96 | 61.91 | 197.03 | 48.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.08 | -0.17 | -0.19 | -0.17 | -0.15 |
| Free Cash Flow Per Share | -0.08 | -0.18 | -0.19 | -0.19 | -0.20 |
| Dividend Paid and CapEx Coverage Ratio | -26.35 | -17.24 | -163.61 | -6.60 | -3.00 |
| Capital Expenditure Coverage Ratio | -26.35 | -17.24 | -163.61 | -7.27 | -3.00 |
| Operating Cash Flow Coverage Ratio | -0.23 | -1.02 | -0.52 | -0.48 | -0.49 |
| Operating Cash Flow to Sales Ratio | -0.19 | -0.58 | -1.48 | -0.80 | -0.15 |
| Free Cash Flow Yield | -9.58% | -8.37% | -26.09% | -31.60% | -15.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.42 | -11.11 | -1.32 | -1.42 | -3.83 |
| Price-to-Sales (P/S) Ratio | 2.03 | 7.34 | 5.69 | 2.88 | 1.25 |
| Price-to-Book (P/B) Ratio | 1.70 | 4.48 | 3.29 | 2.55 | 2.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.44 | -11.95 | -3.83 | -3.16 | -6.34 |
| Price-to-Operating Cash Flow Ratio | -10.84 | -12.65 | -3.86 | -3.60 | -8.45 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.17 | -0.04 | -0.05 | -0.00 |
| Enterprise Value Multiple | -20.92 | -16.22 | -2.69 | -3.30 | -5.87 |
| Enterprise Value | 277.96M | 298.82M | 43.40M | 46.05M | 67.20M |
| EV to EBITDA | -20.92 | -16.22 | -2.69 | -3.30 | -5.87 |
| EV to Sales | 2.68 | 7.67 | 5.93 | 4.42 | 1.41 |
| EV to Free Cash Flow | -13.79 | -12.49 | -3.99 | -4.85 | -7.10 |
| EV to Operating Cash Flow | -14.31 | -13.21 | -4.02 | -5.52 | -9.47 |
| Tangible Book Value Per Share | -0.33 | -0.16 | -0.06 | -0.16 | 0.15 |
| Shareholders’ Equity Per Share | 0.49 | 0.47 | 0.22 | 0.24 | 0.58 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.03 | 0.02 | -0.07 | 0.05 |
| Revenue Per Share | 0.41 | 0.29 | 0.13 | 0.21 | 1.00 |
| Net Income Per Share | -0.19 | -0.19 | -0.55 | -0.42 | -0.33 |
| Tax Burden | 1.18 | 0.93 | 0.97 | 1.23 | 0.96 |
| Interest Burden | 1.32 | 1.10 | 1.86 | 1.04 | 1.03 |
| Research & Development to Revenue | 0.16 | 0.15 | 0.66 | 0.78 | 0.00 |
| SG&A to Revenue | 0.52 | 1.16 | 1.64 | 1.09 | 0.63 |
| Stock-Based Compensation to Revenue | 0.13 | 0.18 | 0.45 | 0.46 | 0.13 |
| Income Quality | 0.50 | 0.82 | 0.34 | 0.40 | 0.46 |
Currency in CAD
